CA2686241C - Compliant blood vessel graft - Google Patents
Compliant blood vessel graft Download PDFInfo
- Publication number
- CA2686241C CA2686241C CA2686241A CA2686241A CA2686241C CA 2686241 C CA2686241 C CA 2686241C CA 2686241 A CA2686241 A CA 2686241A CA 2686241 A CA2686241 A CA 2686241A CA 2686241 C CA2686241 C CA 2686241C
- Authority
- CA
- Canada
- Prior art keywords
- stent
- vein
- vessel
- graft
- diameter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004204 blood vessel Anatomy 0.000 title abstract description 14
- 210000003462 vein Anatomy 0.000 claims abstract description 605
- 238000000034 method Methods 0.000 claims abstract description 125
- 239000000463 material Substances 0.000 claims description 51
- 238000002513 implantation Methods 0.000 claims description 38
- 230000002787 reinforcement Effects 0.000 claims description 13
- 230000002829 reductive effect Effects 0.000 claims description 5
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims 1
- 229910052753 mercury Inorganic materials 0.000 claims 1
- 210000001367 artery Anatomy 0.000 abstract description 97
- 206010020718 hyperplasia Diseases 0.000 abstract description 76
- 241001465754 Metazoa Species 0.000 description 63
- 210000003752 saphenous vein Anatomy 0.000 description 60
- 238000013461 design Methods 0.000 description 58
- 230000003872 anastomosis Effects 0.000 description 55
- 239000007943 implant Substances 0.000 description 44
- 210000001519 tissue Anatomy 0.000 description 43
- 238000005259 measurement Methods 0.000 description 42
- 239000000243 solution Substances 0.000 description 41
- 210000003191 femoral vein Anatomy 0.000 description 34
- 238000002788 crimping Methods 0.000 description 32
- 230000004044 response Effects 0.000 description 31
- 238000004458 analytical method Methods 0.000 description 28
- 239000000853 adhesive Substances 0.000 description 26
- 230000001070 adhesive effect Effects 0.000 description 26
- 239000003292 glue Substances 0.000 description 26
- 239000000835 fiber Substances 0.000 description 25
- 210000001105 femoral artery Anatomy 0.000 description 23
- 229910001000 nickel titanium Inorganic materials 0.000 description 23
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 22
- 238000013459 approach Methods 0.000 description 21
- 238000007634 remodeling Methods 0.000 description 19
- 230000008859 change Effects 0.000 description 18
- 238000011065 in-situ storage Methods 0.000 description 18
- 229910052751 metal Inorganic materials 0.000 description 18
- 230000002792 vascular Effects 0.000 description 18
- 238000001727 in vivo Methods 0.000 description 17
- 239000002184 metal Substances 0.000 description 17
- 238000004513 sizing Methods 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 238000010191 image analysis Methods 0.000 description 16
- 230000010339 dilation Effects 0.000 description 15
- 230000035876 healing Effects 0.000 description 15
- 238000002604 ultrasonography Methods 0.000 description 15
- 241001504519 Papio ursinus Species 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 239000000499 gel Substances 0.000 description 14
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 13
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 13
- 238000000540 analysis of variance Methods 0.000 description 13
- 239000002131 composite material Substances 0.000 description 13
- 238000004422 calculation algorithm Methods 0.000 description 12
- 230000003993 interaction Effects 0.000 description 12
- 238000009940 knitting Methods 0.000 description 12
- 230000004872 arterial blood pressure Effects 0.000 description 11
- 210000004351 coronary vessel Anatomy 0.000 description 11
- 230000006378 damage Effects 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 11
- 230000010412 perfusion Effects 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 210000002808 connective tissue Anatomy 0.000 description 10
- 238000009826 distribution Methods 0.000 description 10
- -1 polyethylene terephthalate Polymers 0.000 description 10
- 241000282520 Papio Species 0.000 description 9
- 239000004792 Prolene Substances 0.000 description 9
- 238000010171 animal model Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 9
- 238000009954 braiding Methods 0.000 description 9
- 230000004087 circulation Effects 0.000 description 9
- 238000007635 classification algorithm Methods 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 239000012781 shape memory material Substances 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 8
- 230000008602 contraction Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000004626 scanning electron microscopy Methods 0.000 description 8
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- 239000002390 adhesive tape Substances 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000035487 diastolic blood pressure Effects 0.000 description 7
- 238000007619 statistical method Methods 0.000 description 7
- 230000035488 systolic blood pressure Effects 0.000 description 7
- 102000016942 Elastin Human genes 0.000 description 6
- 108010014258 Elastin Proteins 0.000 description 6
- 241001111421 Pannus Species 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 239000000956 alloy Substances 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 230000003205 diastolic effect Effects 0.000 description 6
- 229920002549 elastin Polymers 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000004013 groin Anatomy 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 238000000386 microscopy Methods 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 230000007704 transition Effects 0.000 description 6
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 6
- 210000005166 vasculature Anatomy 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 5
- 229910045601 alloy Inorganic materials 0.000 description 5
- 210000000709 aorta Anatomy 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 210000003038 endothelium Anatomy 0.000 description 5
- 230000002349 favourable effect Effects 0.000 description 5
- 239000000834 fixative Substances 0.000 description 5
- 238000009499 grossing Methods 0.000 description 5
- 229960002897 heparin Drugs 0.000 description 5
- 229920000669 heparin Polymers 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000003278 mimic effect Effects 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 210000004872 soft tissue Anatomy 0.000 description 5
- 238000010561 standard procedure Methods 0.000 description 5
- 230000003319 supportive effect Effects 0.000 description 5
- 230000008719 thickening Effects 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 4
- 241000282465 Canis Species 0.000 description 4
- 108010073385 Fibrin Proteins 0.000 description 4
- 102000009123 Fibrin Human genes 0.000 description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 206010060872 Transplant failure Diseases 0.000 description 4
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 238000002583 angiography Methods 0.000 description 4
- 230000002146 bilateral effect Effects 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 239000002872 contrast media Substances 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000011833 dog model Methods 0.000 description 4
- 210000002889 endothelial cell Anatomy 0.000 description 4
- 230000003511 endothelial effect Effects 0.000 description 4
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 4
- 238000013401 experimental design Methods 0.000 description 4
- 229950003499 fibrin Drugs 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 230000002390 hyperplastic effect Effects 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 239000002861 polymer material Substances 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 230000025366 tissue development Effects 0.000 description 4
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 208000010496 Heart Arrest Diseases 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 108091006629 SLC13A2 Proteins 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 230000037444 atrophy Effects 0.000 description 3
- 229910001566 austenite Inorganic materials 0.000 description 3
- 210000000748 cardiovascular system Anatomy 0.000 description 3
- 229940039231 contrast media Drugs 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000002224 dissection Methods 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 210000001349 mammary artery Anatomy 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 238000002559 palpation Methods 0.000 description 3
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papavarine Natural products C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 230000000472 traumatic effect Effects 0.000 description 3
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 206010050456 Anastomotic leak Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 210000002376 aorta thoracic Anatomy 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000004323 axial length Effects 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008512 biological response Effects 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 230000036755 cellular response Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000788 chromium alloy Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000013013 elastic material Substances 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 229910000734 martensite Inorganic materials 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 229920003225 polyurethane elastomer Polymers 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- 210000002321 radial artery Anatomy 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 210000001562 sternum Anatomy 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000007838 tissue remodeling Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 1
- 101100008046 Caenorhabditis elegans cut-2 gene Proteins 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 229910017518 Cu Zn Inorganic materials 0.000 description 1
- 229910017535 Cu-Al-Ni Inorganic materials 0.000 description 1
- 229910017755 Cu-Sn Inorganic materials 0.000 description 1
- 229910017752 Cu-Zn Inorganic materials 0.000 description 1
- 229910017773 Cu-Zn-Al Inorganic materials 0.000 description 1
- 229910017927 Cu—Sn Inorganic materials 0.000 description 1
- 229910017943 Cu—Zn Inorganic materials 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 208000036829 Device dislocation Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000350160 Haematoxylum Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 229910018643 Mn—Si Inorganic materials 0.000 description 1
- 229910003310 Ni-Al Inorganic materials 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 244000137852 Petrea volubilis Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229920006311 Urethane elastomer Polymers 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 description 1
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 1
- 206010072810 Vascular wall hypertrophy Diseases 0.000 description 1
- 229910007610 Zn—Sn Inorganic materials 0.000 description 1
- NOSIYYJFMPDDSA-UHFFFAOYSA-N acepromazine Chemical compound C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 NOSIYYJFMPDDSA-UHFFFAOYSA-N 0.000 description 1
- 229960005054 acepromazine Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000001765 aortic valve Anatomy 0.000 description 1
- 239000012122 aqueous mounting media Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000008321 arterial blood flow Effects 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
- TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical compound [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000011243 crosslinked material Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000003055 full factorial design Methods 0.000 description 1
- 210000004300 gastroepiploic artery Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000001435 haemodynamic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009998 heat setting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 238000013427 histology analysis Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 210000003090 iliac artery Anatomy 0.000 description 1
- KHYBPSFKEHXSLX-UHFFFAOYSA-N iminotitanium Chemical compound [Ti]=N KHYBPSFKEHXSLX-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000002608 intravascular ultrasound Methods 0.000 description 1
- DGAIEPBNLOQYER-UHFFFAOYSA-N iopromide Chemical compound COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I DGAIEPBNLOQYER-UHFFFAOYSA-N 0.000 description 1
- 229960002603 iopromide Drugs 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000012948 isocyanate Chemical class 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000011551 log transformation method Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000088 plastic resin Substances 0.000 description 1
- 229920001693 poly(ether-ester) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 description 1
- 229960000244 procainamide Drugs 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000007409 radiographic assessment Methods 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229920000431 shape-memory polymer Polymers 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000005496 tempering Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 210000002073 venous valve Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
- A61B5/1076—Measuring physical dimensions, e.g. size of the entire body or parts thereof for measuring dimensions inside body cavities, e.g. using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/856—Single tubular stent with a side portal passage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
- A61B2017/1107—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis for blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
- A61B2017/1132—End-to-end connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
- A61B2017/1135—End-to-side connections, e.g. T- or Y-connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
- A61B2017/1139—Side-to-side connections, e.g. shunt or X-connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/002—Designing or making customized prostheses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dentistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/797,648 US7998188B2 (en) | 2003-04-28 | 2007-05-04 | Compliant blood vessel graft |
| US11/797,648 | 2007-05-04 | ||
| PCT/US2008/062370 WO2008137646A1 (en) | 2007-05-04 | 2008-05-02 | Compliant blood vessel graft |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2686241A1 CA2686241A1 (en) | 2008-11-13 |
| CA2686241C true CA2686241C (en) | 2016-07-12 |
Family
ID=38862557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2686241A Expired - Fee Related CA2686241C (en) | 2007-05-04 | 2008-05-02 | Compliant blood vessel graft |
Country Status (6)
| Country | Link |
|---|---|
| US (7) | US7998188B2 (enExample) |
| EP (1) | EP2152198A4 (enExample) |
| JP (1) | JP5331101B2 (enExample) |
| CA (1) | CA2686241C (enExample) |
| WO (1) | WO2008137646A1 (enExample) |
| ZA (1) | ZA200908391B (enExample) |
Families Citing this family (105)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7998188B2 (en) | 2003-04-28 | 2011-08-16 | Kips Bay Medical, Inc. | Compliant blood vessel graft |
| US20050131520A1 (en) | 2003-04-28 | 2005-06-16 | Zilla Peter P. | Compliant blood vessel graft |
| US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
| US7722536B2 (en) | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
| US20060010098A1 (en) | 2004-06-04 | 2006-01-12 | Goodnow Timothy T | Diabetes care host-client architecture and data management system |
| GB0515140D0 (en) * | 2005-07-22 | 2005-08-31 | Ark Therapeutics Ltd | Therapeutic device |
| BRPI0807177B8 (pt) * | 2007-01-30 | 2021-06-22 | Univ Pittsburgh | dispositivo de enxerto de tecido tubular e método de preparação do mesmo |
| US8266791B2 (en) | 2007-09-19 | 2012-09-18 | The Charles Stark Draper Laboratory, Inc. | Method of fabricating microfluidic structures for biomedical applications |
| US20100305686A1 (en) * | 2008-05-15 | 2010-12-02 | Cragg Andrew H | Low-profile modular abdominal aortic aneurysm graft |
| US9149377B2 (en) * | 2008-10-10 | 2015-10-06 | Veryan Medical Ltd. | Stent suitable for deployment in a blood vessel |
| WO2010058406A1 (en) | 2008-11-24 | 2010-05-27 | Vascular Graft Solutions Ltd. | External stent |
| JP5988588B2 (ja) * | 2009-03-10 | 2016-09-07 | ザ ジョーンズ ホプキンズ ユニバーシティＴｈｅ Ｊｏｈｎｓ Ｈｏｐｋｉｎｓ Ｕｎｉｖｅｒｓｉｔｙ | 生物学的組織結合及び修復装置及びその使用方法 |
| US8888840B2 (en) * | 2009-05-20 | 2014-11-18 | Boston Scientific Scimed, Inc. | Drug eluting medical implant |
| US9265633B2 (en) | 2009-05-20 | 2016-02-23 | 480 Biomedical, Inc. | Drug-eluting medical implants |
| US20110319987A1 (en) * | 2009-05-20 | 2011-12-29 | Arsenal Medical | Medical implant |
| CA2762811C (en) * | 2009-05-20 | 2023-03-21 | Arsenal Medical, Inc. | Self-expandable medical device comprising polymeric strands and coatings thereon |
| WO2011041531A1 (en) | 2009-09-30 | 2011-04-07 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
| EP2493418B1 (en) | 2009-10-28 | 2017-03-15 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Bioerodible wraps and uses therefor |
| DE102009052349A1 (de) * | 2009-11-07 | 2011-08-04 | E.S. Bio- Tech Ltd. | Vorrichtung zur Beeinflussung des Blutdrucks |
| EP2512369B8 (en) | 2009-12-16 | 2017-05-17 | Neograft Technologies, Inc. | Graft devices and methods of use |
| US9295541B2 (en) | 2009-12-31 | 2016-03-29 | Neograft Technologies, Inc. | Graft devices and methods of fabrication |
| US9445874B2 (en) | 2010-07-19 | 2016-09-20 | Neograft Technologies, Inc. | Graft devices and methods of use |
| US9042670B2 (en) * | 2010-09-17 | 2015-05-26 | Beamr Imaging Ltd | Downsizing an encoded image |
| US9579193B2 (en) | 2010-09-23 | 2017-02-28 | Transmural Systems Llc | Methods and systems for delivering prostheses using rail techniques |
| US10321998B2 (en) | 2010-09-23 | 2019-06-18 | Transmural Systems Llc | Methods and systems for delivering prostheses using rail techniques |
| WO2012092138A2 (en) | 2010-12-29 | 2012-07-05 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | System and method for mandrel-less electrospinning |
| WO2012097229A2 (en) | 2011-01-14 | 2012-07-19 | Neograft Technologies, Inc. | Apparatus for creating graft devices |
| US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
| WO2012143925A1 (en) | 2011-04-18 | 2012-10-26 | Vascular Graft Solutions Ltd | Devices and methods for deploying implantable sleeves over blood vessels |
| US20160045304A1 (en) * | 2011-04-18 | 2016-02-18 | Eyal Orion | External support for elongated bodily vessels |
| US9186266B2 (en) | 2011-04-18 | 2015-11-17 | Vascular Graft Solutions Ltd. | External support for elongated bodily vessels |
| WO2013016349A2 (en) | 2011-07-25 | 2013-01-31 | Neograft Technologies, Inc. | Vessel treatment methods and devices for use in a graft device |
| US9549817B2 (en) | 2011-09-22 | 2017-01-24 | Transmural Systems Llc | Devices, systems and methods for repairing lumenal systems |
| KR101330397B1 (ko) * | 2011-11-01 | 2013-11-15 | 재단법인 아산사회복지재단 | 자가 팽창성을 가지는 물질 또는 구조를 이용한 혈관 문합용 구조물 및 이를 이용한 혈관 문합 방법 |
| US8758427B2 (en) | 2011-12-02 | 2014-06-24 | Vascular Solutions, Inc. | Elongated expandable member for occluding varicose veins |
| WO2013090337A1 (en) | 2011-12-13 | 2013-06-20 | Neograft Technologies, Inc. | System and atraumatic mandrel for creating graft devices |
| US20130246127A1 (en) * | 2012-03-15 | 2013-09-19 | Aptitude, Llc | Method, apparatus, and computer program product for a pricing utility |
| JP5908811B2 (ja) * | 2012-09-07 | 2016-04-26 | 有限会社ナイセム | 長期間生体内植え込み用極細繊維製医療材料 |
| US12053378B2 (en) | 2012-11-07 | 2024-08-06 | Transmural Systems Llc | Devices, systems and methods for repairing lumenal systems |
| ES3000436T3 (en) * | 2012-12-12 | 2025-02-28 | Lightlab Imaging Inc | Apparatus for automated determination of a lumen contour of a blood vessel |
| HK1214749A1 (zh) * | 2013-01-06 | 2016-08-05 | 医药连接技术-医连技术-M.C.T.有限公司 | 连接器 |
| US9173591B2 (en) | 2013-03-08 | 2015-11-03 | Lightlab Imaging, Inc. | Stent visualization and malapposition detection systems, devices, and methods |
| WO2014160083A1 (en) * | 2013-03-13 | 2014-10-02 | Applied Cardiovascular Solutions, Llc. | Methods, compositions, and devices for the occlusion of cavities and passageways |
| US9173718B2 (en) * | 2013-03-27 | 2015-11-03 | Terumo Cardiovascular Systems Corporation | Blood vessel marking system |
| US10726456B2 (en) | 2013-07-15 | 2020-07-28 | Aptitude, Llc | Method, apparatus, and computer program product for providing a virtual aggregation group |
| CA2918936C (en) * | 2013-07-22 | 2022-01-04 | Atrium Medical Corporation | Graft with expandable region and methods of making and using the same |
| US9675361B2 (en) | 2014-02-28 | 2017-06-13 | Cook Medical Technologies Llc | Coil occlusion device |
| US20170014115A1 (en) | 2014-03-27 | 2017-01-19 | Transmural Systems Llc | Devices and methods for closure of transvascular or transcameral access ports |
| KR102454789B1 (ko) * | 2014-05-29 | 2022-10-17 | 액세스클로저, 아이엔씨. | 키토산 및 폴리에틸렌 글리콜 공중합체 및 이를 사용하여 혈관 천공을 밀봉하기 위한 방법 및 디바이스 |
| ES2744900T3 (es) * | 2014-07-24 | 2020-02-26 | Lightlab Imaging Inc | Visualización de endoprótesis vasculares y vasos sanguíneos y procedimientos de diagnóstico |
| DE102014115337A1 (de) * | 2014-10-21 | 2016-04-21 | Nasib Dlaikan-Campos | Stent zum Schienen einer Vene und System zum Setzen eines Stents |
| US10857012B2 (en) * | 2015-01-20 | 2020-12-08 | Neurogami Medical, Inc. | Vascular implant |
| US10736730B2 (en) | 2015-01-20 | 2020-08-11 | Neurogami Medical, Inc. | Vascular implant |
| US10925611B2 (en) | 2015-01-20 | 2021-02-23 | Neurogami Medical, Inc. | Packaging for surgical implant |
| EP3247285B1 (en) | 2015-01-20 | 2021-08-11 | Neurogami Medical, Inc. | Micrograft for the treatment of intracranial aneurysms |
| US11484319B2 (en) | 2015-01-20 | 2022-11-01 | Neurogami Medical, Inc. | Delivery system for micrograft for treating intracranial aneurysms |
| US9943314B2 (en) | 2015-04-14 | 2018-04-17 | Teleflex Innovations S.À.R.L. | Magnetically-driven delivery assembly and method |
| WO2016168706A1 (en) * | 2015-04-15 | 2016-10-20 | Vanderbilt University | Development and vascular applications of shape memory external stents |
| US10140712B2 (en) | 2015-05-17 | 2018-11-27 | Lightlab Imaging, Inc. | Detection of stent struts relative to side branches |
| US10222956B2 (en) | 2015-05-17 | 2019-03-05 | Lightlab Imaging, Inc. | Intravascular imaging user interface systems and methods |
| US9996921B2 (en) | 2015-05-17 | 2018-06-12 | LIGHTLAB IMAGING, lNC. | Detection of metal stent struts |
| US10646198B2 (en) | 2015-05-17 | 2020-05-12 | Lightlab Imaging, Inc. | Intravascular imaging and guide catheter detection methods and systems |
| US10109058B2 (en) | 2015-05-17 | 2018-10-23 | Lightlab Imaging, Inc. | Intravascular imaging system interfaces and stent detection methods |
| US20160378918A1 (en) | 2015-06-23 | 2016-12-29 | Novation, LLC | Methods And Systems For Providing Improved Mechanism for Updating Healthcare Information Systems |
| CN112315427B (zh) * | 2015-07-25 | 2024-08-09 | 光学实验室成像公司 | 血管内数据可视化方法 |
| JP6869967B2 (ja) | 2015-09-15 | 2021-05-12 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービスＴｈｅ Ｕｎｉｔｅｄ Ｓｔａｔｅｓ Ｏｆ Ａｍｅｒｉｃａ， Ａｓ Ｒｅｐｒｅｓｅｎｔｅｄ Ｂｙ Ｔｈｅ Ｓｅｃｒｅｔａｒｙ， Ｄｅｐａｒｔｍｅｎｔ Ｏｆ Ｈｅａｌｔｈ Ａｎｄ Ｈｕｍａｎ Ｓｅｒｖｉｃｅ | 経皮的グレン並びにフォンタン手術を実施するための装置及び方法 |
| US20170080182A1 (en) * | 2015-09-23 | 2017-03-23 | Brian William Rotenberg | Bilateral Frontal Sinus Device |
| EP3640321B1 (en) * | 2015-10-09 | 2022-04-06 | DEKA Products Limited Partnership | Method for generating a tissue for transplant |
| EP3871589B1 (en) | 2015-11-18 | 2025-03-05 | Lightlab Imaging, Inc. | Detection of stent struts relative to side branches |
| ES2851548T3 (es) | 2015-11-23 | 2021-09-07 | Lightlab Imaging Inc | Detección y validación de sombras en imágenes intravasculares |
| JP6578022B2 (ja) * | 2016-01-18 | 2019-09-18 | 旭化成株式会社 | 医療用布帛 |
| US9579187B1 (en) * | 2016-02-10 | 2017-02-28 | Stanislaw L Zukowski | Radially compliant pressure indicating stent graft |
| WO2017161080A1 (en) | 2016-03-17 | 2017-09-21 | Rugart Eric S | Organ enclosures for inhibiting tumor invasion and detecting organ pathology |
| CN116309390A (zh) | 2016-04-14 | 2023-06-23 | 光学实验室成像公司 | 血管分支的识别 |
| WO2017201026A1 (en) | 2016-05-16 | 2017-11-23 | Lightlab Imaging, Inc. | Intravascular absorbable stent detection and diagnostic methods and systems |
| US10420563B2 (en) | 2016-07-08 | 2019-09-24 | Neurogami Medical, Inc. | Delivery system insertable through body lumen |
| CN109716446B (zh) | 2016-09-28 | 2023-10-03 | 光学实验室成像公司 | 利用血管表象的支架规划系统及方法 |
| US11299705B2 (en) | 2016-11-07 | 2022-04-12 | Deka Products Limited Partnership | System and method for creating tissue |
| AU2017371223B2 (en) | 2016-12-09 | 2023-04-27 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra |
| KR102593376B1 (ko) | 2017-03-31 | 2023-10-24 | 인아배스크 메디컬, 인코퍼레이티드. | 혈관 통로 이식편의 캐뉼러 삽입을 위한 장치 및 방법 |
| JP6967265B2 (ja) * | 2017-04-28 | 2021-11-17 | 株式会社彩 | 医療用基材の評価方法及び製造方法 |
| US10781976B2 (en) | 2017-05-03 | 2020-09-22 | Johns Manville | Systems and methods for compression pack pipe insulation |
| US20200129667A1 (en) * | 2017-06-30 | 2020-04-30 | Vascudyne Inc | Regenerative tissue and natural tissue implants |
| EP3691568B1 (en) | 2017-09-01 | 2024-08-28 | Transmural Systems LLC | Percutaneous shunt devices |
| US11395725B2 (en) | 2017-09-19 | 2022-07-26 | Lifenet Health | Aortoiliac implant and processing and uses thereof |
| WO2019075038A1 (en) * | 2017-10-11 | 2019-04-18 | Aquedeon Medical, Inc. | SYSTEMS AND METHODS FOR TREATING AORTIC DISSECTION |
| US11065136B2 (en) | 2018-02-08 | 2021-07-20 | Covidien Lp | Vascular expandable devices |
| US11065009B2 (en) | 2018-02-08 | 2021-07-20 | Covidien Lp | Vascular expandable devices |
| EP3764921A1 (en) | 2018-03-16 | 2021-01-20 | Boston Scientific Scimed Inc. | Devices for vein closure |
| US11844711B2 (en) * | 2018-03-29 | 2023-12-19 | SB-Kawasumi Laboratories, Inc. | Stent |
| US11087453B2 (en) * | 2018-06-11 | 2021-08-10 | Dynatek Labs, Inc. | Automated failure detection for medical device testing systems and methods |
| RU187447U1 (ru) * | 2018-11-22 | 2019-03-06 | Закрытое акционерное общество "НеоКор" (ЗАО "НеоКор") | Биологический протез артерий с наружным сетчатым трубчатым покрытием внешней стенки |
| US11998467B2 (en) | 2019-01-28 | 2024-06-04 | Tensor Flow Ventures Llc | Stent delivery for vascular surgery |
| US11666464B2 (en) * | 2019-01-28 | 2023-06-06 | Tensor Flow Ventures Llc | Magnetic stent and stent delivery |
| CA3156685A1 (en) | 2019-11-19 | 2021-05-27 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment and imaging of an implant in the prostatic urethra |
| CN115279428A (zh) * | 2020-03-03 | 2022-11-01 | 萩原明郎 | 静脉套 |
| CN115666445A (zh) * | 2020-04-08 | 2023-01-31 | 莱兰斯坦福初级大学评议会 | 防止自体和异种移植失败的系统、装置和方法 |
| CN112072164B (zh) * | 2020-08-28 | 2023-05-12 | 蜂巢能源科技有限公司 | 固态锂电池及其制备方法 |
| EP4247306A4 (en) * | 2020-11-18 | 2024-10-30 | Microvention, Inc. | TREATMENT OF FUSIFORM ANEURYSM |
| US11291565B1 (en) | 2021-04-22 | 2022-04-05 | Vascular Graft Solutions Ltd. | Asymmetric external support for stabilizing a vein graft used in a coronary arterial bypass graft (CABG) procedure, and applications thereof |
| US20230026939A1 (en) | 2021-07-26 | 2023-01-26 | Tensor Flow Ventures Llc | Dual stent and delivery system, delivery tool apparatus, and method of delivery of dual stents |
| US20230277348A1 (en) | 2021-07-26 | 2023-09-07 | Tensor Flow Ventures Llc | Dual stent and delivery system, delivery tool apparatus, and method of delivery of dual stents |
| WO2023137142A2 (en) * | 2022-01-14 | 2023-07-20 | President And Fellows Of Harvard College | Active tissue adhesive and uses thereof |
| CN115969593A (zh) * | 2022-12-06 | 2023-04-18 | 中国人民解放军空军军医大学 | 载药型3d打印可降解静脉外支架及其构建方法 |
| US12127928B2 (en) | 2022-12-06 | 2024-10-29 | Medical 21, Inc. | Composite implant |
Family Cites Families (124)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3337673A (en) | 1958-07-31 | 1967-08-22 | Us Catheter & Instr Corp | Uniformly corrugated prosthesis and process of making same |
| US3626947A (en) | 1970-02-19 | 1971-12-14 | Charles Howard Sparks | Method and apparatus for vein and artery reenforcement |
| US3797485A (en) | 1971-03-26 | 1974-03-19 | Alza Corp | Novel drug delivery device for administering drug into blood circulation in blood vessel |
| US3974526A (en) | 1973-07-06 | 1976-08-17 | Dardik Irving I | Vascular prostheses and process for producing the same |
| US4173689A (en) | 1976-02-03 | 1979-11-06 | University Of Utah | Synthetic polymer prosthesis material |
| US4502159A (en) * | 1982-08-12 | 1985-03-05 | Shiley Incorporated | Tubular prostheses prepared from pericardial tissue |
| EP0128501B1 (en) | 1983-06-06 | 1989-03-29 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Artificial vessel and process for preparing the same |
| DE3478192D1 (en) | 1983-06-06 | 1989-06-22 | Kanegafuchi Chemical Ind | Artificial vessel and process for preparing the same |
| FR2556210B1 (fr) | 1983-12-08 | 1988-04-15 | Barra Jean Aubert | Prothese veineuse et son procede d'obtention |
| US4652264A (en) | 1985-04-25 | 1987-03-24 | American Cyanamid Company | Prosthetic tubular article |
| DE3682734D1 (de) | 1985-08-23 | 1992-01-16 | Kanegafuchi Chemical Ind | Kuenstliches gefaess. |
| DE3640745A1 (de) | 1985-11-30 | 1987-06-04 | Ernst Peter Prof Dr M Strecker | Katheter zum herstellen oder erweitern von verbindungen zu oder zwischen koerperhohlraeumen |
| US4956178A (en) | 1988-07-11 | 1990-09-11 | Purdue Research Foundation | Tissue graft composition |
| US5207705A (en) | 1988-12-08 | 1993-05-04 | Brigham And Women's Hospital | Prosthesis of foam polyurethane and collagen and uses thereof |
| US4969896A (en) | 1989-02-01 | 1990-11-13 | Interpore International | Vascular graft prosthesis and method of making the same |
| US5609626A (en) | 1989-05-31 | 1997-03-11 | Baxter International Inc. | Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts |
| US6063723A (en) | 1990-03-02 | 2000-05-16 | Chevron U.S.A. Inc. | Sulfur tolerant zeolite catalyst |
| JPH03260178A (ja) | 1990-03-06 | 1991-11-20 | Showa Shell Sekiyu Kk | 吸水保水性柔軟クロスの製造法 |
| US5681645A (en) | 1990-03-30 | 1997-10-28 | Kimberly-Clark Corporation | Flat elastomeric nonwoven laminates |
| US5320100A (en) | 1991-09-16 | 1994-06-14 | Atrium Medical Corporation | Implantable prosthetic device having integral patency diagnostic indicia |
| US5662713A (en) | 1991-10-09 | 1997-09-02 | Boston Scientific Corporation | Medical stents for body lumens exhibiting peristaltic motion |
| US5366504A (en) | 1992-05-20 | 1994-11-22 | Boston Scientific Corporation | Tubular medical prosthesis |
| US7101392B2 (en) | 1992-03-31 | 2006-09-05 | Boston Scientific Corporation | Tubular medical endoprostheses |
| EP0633798B1 (en) | 1992-03-31 | 2003-05-07 | Boston Scientific Corporation | Vascular filter |
| US5405378A (en) * | 1992-05-20 | 1995-04-11 | Strecker; Ernst P. | Device with a prosthesis implantable in the body of a patient |
| US5628782A (en) | 1992-12-11 | 1997-05-13 | W. L. Gore & Associates, Inc. | Method of making a prosthetic vascular graft |
| US5716395A (en) | 1992-12-11 | 1998-02-10 | W.L. Gore & Associates, Inc. | Prosthetic vascular graft |
| WO1994021197A1 (en) | 1993-03-25 | 1994-09-29 | C.R. Bard, Inc. | Vascular graft |
| US5913894A (en) | 1994-12-05 | 1999-06-22 | Meadox Medicals, Inc. | Solid woven tubular prosthesis |
| US5723004A (en) | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
| DE4340755C1 (de) * | 1993-11-30 | 1995-06-29 | Zurbruegg Heinz R | Gefäßprothese |
| DE69533952T2 (de) | 1994-02-07 | 2006-01-12 | Kabushiki Kaisha Igaki Iryo Sekkei | Stentvorrichtung und stentversorgungssystem |
| US5478349A (en) | 1994-04-28 | 1995-12-26 | Boston Scientific Corporation | Placement of endoprostheses and stents |
| US5584876A (en) | 1994-04-29 | 1996-12-17 | W. L. Gore & Associates, Inc. | Cell excluding sheath for vascular grafts |
| CA2147547C (en) | 1994-08-02 | 2006-12-19 | Peter J. Schmitt | Thinly woven flexible graft |
| US5702419A (en) * | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
| EP1477132A3 (en) | 1994-10-17 | 2009-09-09 | Kabushikikaisha Igaki Iryo Sekkei | Drug-releasing stent |
| US5681345A (en) | 1995-03-01 | 1997-10-28 | Scimed Life Systems, Inc. | Sleeve carrying stent |
| US5556414A (en) | 1995-03-08 | 1996-09-17 | Wayne State University | Composite intraluminal graft |
| GB2298577B (en) | 1995-03-09 | 1999-02-17 | Univ Bristol | Arteriovenous bypass grafting |
| US6053943A (en) | 1995-12-08 | 2000-04-25 | Impra, Inc. | Endoluminal graft with integral structural support and method for making same |
| US6264684B1 (en) | 1995-03-10 | 2001-07-24 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Helically supported graft |
| RU2102016C1 (ru) | 1995-07-07 | 1998-01-20 | Московский государственный институт стали и сплавов (технологический университет) | Устройство для экстравазальной коррекции функции клапанов магистральных вен |
| WO1996038090A1 (fr) | 1995-06-01 | 1996-12-05 | Moskovsky Gosudarstvenny Institut Stali I Splavov Tekhnologichesky Universitet | Procede de correction extra-vasculaire du mauvais fonctionnement des valvules de veines et correcteur extra-vasculaire pour la mise en ×uvre de ce procede |
| US5900433A (en) | 1995-06-23 | 1999-05-04 | Cormedics Corp. | Vascular treatment method and apparatus |
| US6428571B1 (en) | 1996-01-22 | 2002-08-06 | Scimed Life Systems, Inc. | Self-sealing PTFE vascular graft and manufacturing methods |
| JP2000509307A (ja) | 1996-04-30 | 2000-07-25 | メドトロニック，インコーポレイテッド | 自己由来フィブリン密封材の製造方法 |
| WO2000062828A1 (en) | 1996-04-30 | 2000-10-26 | Medtronic, Inc. | Autologous fibrin sealant and method for making the same |
| FR2748199B1 (fr) | 1996-05-02 | 1998-10-09 | Braun Celsa Sa | Prothese vasculaire transcutanee chirurgicalement anastomosable |
| US5769884A (en) | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
| US5728150A (en) | 1996-07-29 | 1998-03-17 | Cardiovascular Dynamics, Inc. | Expandable microporous prosthesis |
| US5797887A (en) | 1996-08-27 | 1998-08-25 | Novovasc Llc | Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation |
| US5868763A (en) | 1996-09-16 | 1999-02-09 | Guidant Corporation | Means and methods for performing an anastomosis |
| US5824047A (en) | 1996-10-11 | 1998-10-20 | C. R. Bard, Inc. | Vascular graft fabric |
| US5755778A (en) | 1996-10-16 | 1998-05-26 | Nitinol Medical Technologies, Inc. | Anastomosis device |
| US5972017A (en) | 1997-04-23 | 1999-10-26 | Vascular Science Inc. | Method of installing tubular medical graft connectors |
| SK71399A3 (en) | 1996-12-10 | 2000-05-16 | Purdue Research Foundation | Tubular submucosal graft constructs |
| US6048360A (en) | 1997-03-18 | 2000-04-11 | Endotex Interventional Systems, Inc. | Methods of making and using coiled sheet graft for single and bifurcated lumens |
| US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
| GB9709967D0 (en) * | 1997-05-17 | 1997-07-09 | Harris Peter L | Prosthetic grafts |
| GB9710905D0 (en) | 1997-05-27 | 1997-07-23 | Imperial College | Stent for blood vessel |
| EP1017336B1 (en) * | 1997-09-24 | 2007-08-15 | Med Institute, Inc. | Radially expandable stent |
| US6161399A (en) | 1997-10-24 | 2000-12-19 | Iowa-India Investments Company Limited | Process for manufacturing a wire reinforced monolayer fabric stent |
| US6117166A (en) | 1997-10-27 | 2000-09-12 | Winston; Thomas R. | Apparatus and methods for grafting blood vessel tissue |
| WO1999026559A1 (en) | 1997-11-25 | 1999-06-03 | Triad Vascular Systems, Inc. | Layered endovascular graft |
| US6117535A (en) | 1998-01-14 | 2000-09-12 | Cardiotech International, Inc. | Biocompatible devices |
| US6187038B1 (en) | 1998-04-08 | 2001-02-13 | Sulzer Carbomedics Inc. | Small bore biologic graft with therapeutic delivery system |
| US5989287A (en) | 1998-05-06 | 1999-11-23 | Av Healing Llc | Vascular graft assemblies and methods for implanting same |
| EP1083843A4 (en) | 1998-06-05 | 2005-06-08 | Organogenesis Inc | GRAFTED VASCULAR PROSTHESES OBTAINED BY GENIE BIOMEDICAL |
| MXPA00012061A (es) | 1998-06-05 | 2003-04-22 | Organogenesis Inc | Protesis de injerto vascular biodisenadas. |
| US6217609B1 (en) | 1998-06-30 | 2001-04-17 | Schneider (Usa) Inc | Implantable endoprosthesis with patterned terminated ends and methods for making same |
| US6156064A (en) | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
| US6159239A (en) | 1998-08-14 | 2000-12-12 | Prodesco, Inc. | Woven stent/graft structure |
| US6152937A (en) | 1998-11-06 | 2000-11-28 | St. Jude Medical Cardiovascular Group, Inc. | Medical graft connector and methods of making and installing same |
| US6113612A (en) | 1998-11-06 | 2000-09-05 | St. Jude Medical Cardiovascular Group, Inc. | Medical anastomosis apparatus |
| US6336937B1 (en) * | 1998-12-09 | 2002-01-08 | Gore Enterprise Holdings, Inc. | Multi-stage expandable stent-graft |
| US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
| US6077298A (en) | 1999-02-20 | 2000-06-20 | Tu; Lily Chen | Expandable/retractable stent and methods thereof |
| DE19910340A1 (de) | 1999-03-09 | 2000-09-21 | Juergen C Froelich | Verbessertes autologes Venentransplantat |
| US6180738B1 (en) | 1999-06-29 | 2001-01-30 | Union Carbide Chemicals & Plastics Technology Corporation | Production of a sticky polymer using an improved carbon black |
| US6551351B2 (en) | 1999-07-02 | 2003-04-22 | Scimed Life Systems | Spiral wound stent |
| US6358275B1 (en) | 1999-10-04 | 2002-03-19 | Sulzer Carbomedics Inc. | Tissue-derived vascular grafts and methods for making the same |
| US6364895B1 (en) | 1999-10-07 | 2002-04-02 | Prodesco, Inc. | Intraluminal filter |
| US6375670B1 (en) | 1999-10-07 | 2002-04-23 | Prodesco, Inc. | Intraluminal filter |
| EP1246572B1 (en) | 1999-10-08 | 2005-08-10 | The General Hospital Corporation doing business as Massachusetts General Hospital | Percutaneous stent graft |
| US6319279B1 (en) | 1999-10-15 | 2001-11-20 | Edwards Lifesciences Corp. | Laminated self-sealing vascular access graft |
| US6391037B1 (en) | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
| US6346117B1 (en) | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
| DE60133377T2 (de) | 2000-04-28 | 2009-01-02 | Baylor College Of Medicine, Houston | Dezellularisierte gefässprothesen |
| AU2002211580A1 (en) | 2000-10-10 | 2002-04-22 | Prodesco, Inc. | Stiffened fabric |
| US6814754B2 (en) | 2000-10-30 | 2004-11-09 | Secant Medical, Llc | Woven tubular graft with regions of varying flexibility |
| US6494909B2 (en) | 2000-12-01 | 2002-12-17 | Prodesco, Inc. | Endovascular valve |
| JP2004524909A (ja) * | 2001-03-09 | 2004-08-19 | ジョージア テック リサーチ コーポレイション | 血管の軸方向への伸張のための脈管内デバイスおよび方法 |
| AUPR389201A0 (en) | 2001-03-23 | 2001-04-12 | Lane, Rodney James | Improvements in design of external vendus valve stents for the correction fo incompetent vendods valves |
| US6551352B2 (en) | 2001-05-03 | 2003-04-22 | Bionx Implants, Inc. | Method for attaching axial filaments to a self expanding stent |
| US6716239B2 (en) | 2001-07-03 | 2004-04-06 | Scimed Life Systems, Inc. | ePTFE graft with axial elongation properties |
| US20030110830A1 (en) | 2001-07-23 | 2003-06-19 | Mark Dehdashtian | Methods and apparatuses for measuring the compliance of stents and stented grafts |
| WO2003011184A2 (en) * | 2001-07-27 | 2003-02-13 | Medtronic,Inc. | Adventitial fabric reinforced porous prosthetic graft |
| DE10137414B4 (de) | 2001-07-31 | 2005-12-29 | Aesculap Ag & Co. Kg | Ummantelung für Venen und Verwendung in der Chirurgie |
| US20030204249A1 (en) | 2002-04-25 | 2003-10-30 | Michel Letort | Endovascular stent graft and fixation cuff |
| US20040019375A1 (en) | 2002-07-26 | 2004-01-29 | Scimed Life Systems, Inc. | Sectional crimped graft |
| US7011676B2 (en) | 2002-09-05 | 2006-03-14 | Scimed Life Systems, Inc. | Flat knitted stent and method of making the same |
| US7264631B2 (en) | 2002-09-16 | 2007-09-04 | Scimed Life Systems, Inc. | Devices and methods for AAA management |
| WO2004037152A2 (en) | 2002-10-07 | 2004-05-06 | Pavad Medical, Inc. | Vascular assist device and methods |
| AU2002953440A0 (en) | 2002-12-19 | 2003-01-09 | Unisearch Limited | A method of treating a stiffened vessel |
| US7452374B2 (en) | 2003-04-24 | 2008-11-18 | Maquet Cardiovascular, Llc | AV grafts with rapid post-operative self-sealing capabilities |
| US20050131520A1 (en) * | 2003-04-28 | 2005-06-16 | Zilla Peter P. | Compliant blood vessel graft |
| ES2375566T3 (es) | 2003-04-28 | 2012-03-02 | Kips Bay Medical, Inc. | Injerto venoso distensible. |
| US7998188B2 (en) | 2003-04-28 | 2011-08-16 | Kips Bay Medical, Inc. | Compliant blood vessel graft |
| US6916336B2 (en) | 2003-06-09 | 2005-07-12 | Avantec Vascular Corporation | Vascular prosthesis |
| DE10355986A1 (de) | 2003-11-27 | 2005-06-30 | Forschungszentrum Karlsruhe Gmbh | Kompressionsmanschette |
| US20050177224A1 (en) | 2004-02-11 | 2005-08-11 | Fogarty Thomas J. | Vascular fixation device and method |
| US20060069426A1 (en) | 2004-09-27 | 2006-03-30 | Weinberger Judah Z | Methods and devices for extravascular intervention |
| WO2006050537A2 (en) | 2004-11-03 | 2006-05-11 | Cook Incorporated | Methods for treating valve-associated regions of vascular vessels |
| JP4497057B2 (ja) | 2005-08-23 | 2010-07-07 | 日産自動車株式会社 | 車両の変速制御装置 |
| US8702787B2 (en) | 2005-09-02 | 2014-04-22 | Medtronic Vascular, Inc. | Endoluminal prosthesis |
| US8663308B2 (en) | 2005-09-19 | 2014-03-04 | Cook Medical Technologies Llc | Graft with bioabsorbable support frame |
| US20090171436A1 (en) | 2005-11-09 | 2009-07-02 | Casanova R Michael | Grafts and stent grafts having a radiopaque beading |
| US8778008B2 (en) | 2006-01-13 | 2014-07-15 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of vascular abnormalities |
| US7481836B2 (en) | 2006-03-30 | 2009-01-27 | Medtronic Vascular, Inc. | Prosthesis with coupling zone and methods |
| US8147537B2 (en) | 2006-06-16 | 2012-04-03 | The Invention Science Fund I, Llc | Rapid-prototyped custom-fitted blood vessel sleeve |
| US7575592B2 (en) | 2006-10-03 | 2009-08-18 | St. Jude Medical, Inc. | Synthetic blood vessel grafts |
| BRPI0807177B8 (pt) | 2007-01-30 | 2021-06-22 | Univ Pittsburgh | dispositivo de enxerto de tecido tubular e método de preparação do mesmo |
| US8353814B2 (en) | 2008-10-09 | 2013-01-15 | Kips Bay Medical, Inc. | Apparatus and method for mounting an external scaffold to a vascular graft |
-
2007
- 2007-05-04 US US11/797,648 patent/US7998188B2/en active Active
-
2008
- 2008-05-02 EP EP08747464.9A patent/EP2152198A4/en not_active Withdrawn
- 2008-05-02 JP JP2010506671A patent/JP5331101B2/ja not_active Expired - Fee Related
- 2008-05-02 WO PCT/US2008/062370 patent/WO2008137646A1/en not_active Ceased
- 2008-05-02 CA CA2686241A patent/CA2686241C/en not_active Expired - Fee Related
-
2009
- 2009-11-26 ZA ZA2009/08391A patent/ZA200908391B/en unknown
-
2011
- 2011-08-15 US US13/209,517 patent/US8382814B2/en not_active Expired - Fee Related
-
2013
- 2013-01-21 US US13/745,999 patent/US8747451B2/en not_active Expired - Lifetime
- 2013-10-08 US US14/048,864 patent/US8906082B2/en not_active Expired - Lifetime
-
2014
- 2014-07-31 US US14/448,694 patent/US9517069B2/en not_active Expired - Fee Related
-
2016
- 2016-11-07 US US15/344,998 patent/US10092293B2/en not_active Expired - Lifetime
-
2018
- 2018-07-27 US US16/047,909 patent/US10595868B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US8906082B2 (en) | 2014-12-09 |
| US20140379010A1 (en) | 2014-12-25 |
| US8382814B2 (en) | 2013-02-26 |
| EP2152198A4 (en) | 2015-07-22 |
| US7998188B2 (en) | 2011-08-16 |
| CA2686241A1 (en) | 2008-11-13 |
| US9517069B2 (en) | 2016-12-13 |
| US10092293B2 (en) | 2018-10-09 |
| EP2152198A1 (en) | 2010-02-17 |
| JP2010525898A (ja) | 2010-07-29 |
| WO2008137646A1 (en) | 2008-11-13 |
| US20070293932A1 (en) | 2007-12-20 |
| US20140039352A1 (en) | 2014-02-06 |
| US20130144374A1 (en) | 2013-06-06 |
| US20170296192A1 (en) | 2017-10-19 |
| US20110295157A1 (en) | 2011-12-01 |
| US8747451B2 (en) | 2014-06-10 |
| JP5331101B2 (ja) | 2013-10-30 |
| US10595868B2 (en) | 2020-03-24 |
| ZA200908391B (en) | 2013-04-24 |
| US20190239879A1 (en) | 2019-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10595868B2 (en) | Graft apparatus | |
| US9517121B2 (en) | Compliant blood vessel graft | |
| EP1626679B1 (en) | Compliant venous graft | |
| US11826029B2 (en) | Self-closing devices and methods for making and using them | |
| US20170258609A1 (en) | Vessel remodeling methods and devices for use in a graft device | |
| Yoffe et al. | Experimental study of a novel suture-less aortic anastomotic device | |
| EP1827300A1 (en) | Compliant blood vessel graft | |
| AU2024257551A1 (en) | External support for a tissue implant | |
| WO2019175888A1 (en) | Expandable endo prosthesis with low crimp profile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20130429 |
|
| MKLA | Lapsed |
Effective date: 20220301 |
|
| MKLA | Lapsed |
Effective date: 20200831 |